Insurer profitability remained strong in Q3 despite unexpectedly high COVID-19 costs
For most payers, higher-than-expected coronavirus costs were offset by patients continuing to delay nonessential medical care.
For most payers, higher-than-expected coronavirus costs were offset by patients continuing to delay nonessential medical care.
The drugmaker, which last week won FDA clearance of its vaccine in younger children, plans to quickly ask the agency for emergency authorization of the drug in high-risk patients.
The deal was reached on six contracts covering about 2,500 employees at Catholic Health, according to the New York hospital. The union was originally pushing for one master contract.
Legislation backed by President Joe Biden and top Democratic lawmakers would allow for price negotiation on up to 20 older drugs, potentially impacting blockbusters from Pfizer, Bristol Myers Squibb and others.
The work stoppage could pose a significant challenge to operations in Kaiser’s southern California market, where the unions poised to strike represent about 37% of the system’s workforce in the region.
Currently, at-risk membership makes up less than 5% of One Medical’s overall membership base. But Medicare revenue in the quarter made up more than a fifth of the primary care chain’s topline.
Bradley Merrill Thompson, an attorney at Epstein Becker Green, said the new guidance is sorely needed by the medical device industry. “In the realm of software, [16 years is] an eternity,” Thompson said.
Hospitals, ambulatory surgery centers, long-term care facilities and others that receive federal funding from Medicare or Medicaid will have to ensure employees are fully vaccinated by Jan. 4 before they provide any care to patients.
Consummation of UnitedHealth’s $13 billion Change acquisition is now teed up for February at the earliest, though the deal could close even sooner if the DOJ unexpectedly drops its investigation — or later, if the agency challenges.
Those surveyed showed the widest support for policy changes that could lower drug costs, followed by measures limiting what both hospitals and doctors can charge for services, according to the Robert Wood Johnson Foundation.